{"url_path":"/sec/cvs/8-k/2026-05-18/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/64803/0000064803-26-000082-index.html","accession_number":"0000064803-26-000082","cik":"0000064803","ticker":"CVS","issuer_name":"CVS HEALTH Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/64803/0000064803-26-000082-index.html","primary_entity_key":"0000064803","primary_entity_name":"CVS HEALTH Corp"},"word_count":482,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nAs noted above, the Company’s Annual Meeting was held on May 14, 2026. The following are the voting results on each matter submitted to the stockholders of the Company at the Annual Meeting. The proposals below are described in detail in the Proxy Statement. There were present at the Annual Meeting, in person or by valid proxy, the holders of 1,142,802,406 shares of the Company’s common stock, constituting a quorum.\n\nAt the Annual Meeting, the 13 nominees for director were elected to the Company’s Board of Directors for a term of one year (Item 1). The Company proposal regarding the ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026 (Item 2) was approved. The Company proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement (Item 3) was approved. The Company proposal to approve the Company’s 2026 ICP (Item 4) was approved. One stockholder proposal (Item 5) was not approved.\n\nItemForAgainstAbstainedBroker Non-Votes\n\n1.The election, for one-year terms, of persons nominated for election as directors of the Company, as set forth in the Company’s Proxy Statement, was approved by the following votes:\n\nFernando Aguirre1,022,555,114 14,973,034 1,190,326 104,083,932 \n\nJeffrey R. Balser, M.D., Ph.D.1,027,705,454 9,787,711 1,225,309 104,083,932 \n\nC. David Brown II963,381,905 74,082,639 1,253,930 104,083,932 \n\nAlecia A. DeCoudreaux996,234,731 41,326,102 1,157,641 104,083,932 \n\nAnne M. Finucane1,010,527,586 27,032,194 1,158,694 104,083,932 \n\nJohn E. Gallina1,024,886,453 12,566,628 1,265,393 104,083,932 \n\nJ. David Joyner 968,110,706 66,554,762 4,053,006 104,083,932 \n\nJ. Scott Kirby995,832,249 41,667,652 1,218,573 104,083,932 \n\nMichael F. Mahoney 940,279,615 96,450,126 1,988,733 104,083,932 \n\nLeslie V. Norwalk1,021,952,646 15,580,839 1,184,989 104,083,932 \n\nLarry M. Robbins 1,026,332,859 11,150,192 1,235,423 104,083,932 \n\nGuy P. Sansone 995,433,957 42,056,031 1,228,486 104,083,932 \n\nDouglas H. Shulman1,020,665,806 16,793,215 1,259,453 104,083,932 \n\n2.Company proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026, as set forth in the Company’s Proxy Statement, was approved by the following vote:1,117,411,640 24,102,167 1,288,599 None\n\n3.Company proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers, as set forth in the Company’s Proxy Statement, was approved by the following vote:976,252,194 59,088,923 3,377,357 104,083,932 \n\n4.Company proposal to approve the Company’s 2026 Incentive Compensation Plan, as set forth in the Company's Proxy Statement, was approved by the following vote:1,006,709,390 28,851,289 3,157,795 104,083,932 \n\n5.Stockholder proposal for reducing the threshold for the Company’s stockholder right to act by written consent, as set forth in the Company’s Proxy Statement, was not approved by the following vote:417,969,177 617,361,014 3,388,283 104,083,932 \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nCVS HEALTH CORPORATION\n\nDate: May 18, 2026By:/s/ Kristina V. Fink\n\nKristina V. Fink\n\nSenior Vice President, Corporate Secretary and Chief\n\nGovernance Officer"}